Search Results - VanderWeele, David

PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER by VanderWeele, David J., Turkbey, Baris, Sowalsky, Adam G.

Get full text Get full text Get full text

Can post-neoadjuvant therapy molecular classification guide future treatment selection for muscle-invasive bladder cancer? by VanderWeele, David J., Meeks, Joshua J., Hussain, Maha

Get full text Get full text Get full text

Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer – A Case Report by VanderWeele, David J., Paner, Gladell P., Fleming, Gini F., Szmulewitz, Russell Z.

Get full text Get full text Get full text

Circulating tumor cells capture disease evolution in advanced prostate cancer by Lack, Justin, Gillard, Marc, Cam, Maggie, Paner, Gladell P., VanderWeele, David J.

Get full text Get full text Get full text

Past, Current, and Future of Immunotherapies for Prostate Cancer by Boettcher, Adeline N., Usman, Ahmed, Morgans, Alicia, VanderWeele, David J., Sosman, Jeffrey, Wu, Jennifer D.

Get full text Get full text Get full text

Next-gen tissue: preservation of molecular and morphological fidelity in prostate tissue by Gillard, Marc, Tom, Westin R, Antic, Tatjana, Paner, Gladell P, Lingen, Mark W, VanderWeele, David J

Get full text Get full text

Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience by Polineni, Praneet, Ashack, Laura, Kalapurakal, John, Morgans, Alicia, VanderWeele, David, Kundu, Shilajit, Hussain, Maha, Meeks, Joshua, Sachdev, Sean

Get full text Get full text Get full text

Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prosta... by Reyes, Edwin E, VanderWeele, David J, Isikbay, Masis, Duggan, Ryan, Campanile, Alexa, Stadler, Walter M, Vander Griend, Donald J, Szmulewitz, Russell Z

Get full text Get full text Get full text

Low-grade prostate cancer diverges early from high grade and metastatic disease by VanderWeele, David J, Brown, Christopher D, Taxy, Jerome B, Gillard, Marc, Hatcher, David M, Tom, Westin R, Stadler, Walter M, White, Kevin P

Get full text Get full text Get full text

Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer by Gillard, Marc, Lack, Justin, Pontier, Andrea, Gandla, Divya, Hatcher, David, Sowalsky, Adam G., Rodriguez-Nieves, Jose, Vander Griend, Donald, Paner, Gladell, VanderWeele, David

Get full text Get full text Get full text

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells by Hulleman, Esther, Kazemier, Karin M., Holleman, Amy, VanderWeele, David J., Rudin, Charles M., Broekhuis, Mathilde J. C., Evans, William E., Pieters, Rob, Den Boer, Monique L.

Get full text Get full text Get full text

Targeting the PI3K/AKT pathway overcomes enzalutamide resistance by inhibiting induction of the glucocorticoid receptor by Adelaiye-Ogala, Remi, Gryder, Berkley E., Nguyen, Yen Thi Minh, Alilin, Aian Neil, Grayson, Adlai R., Bajwa, Wardah, Jansson, Keith H., Beshiri, Michael L., Agarwal, Supreet, Rodriguez-Nieves, Jose Antonio, Capaldo, Brian, Kelly, Kathleen, VanderWeele, David J.

Get full text Get full text Get full text

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy by Gold, Samuel A., VanderWeele, David J., Harmon, Stephanie, Bloom, Jonathan B., Karzai, Fatima, Hale, Graham R., Marhamati, Shawn, Rayn, Kareem N., Mehralivand, Sherif, Merino, Maria J., Gulley, James L., Bilusic, Marijo, Madan, Ravi A., Choyke, Peter L., Turkbey, Baris, Dahut, William, Pinto, Peter A.

Get full text Get full text Get full text

Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy by VanderWeele, David J., Finney, Richard, Katayama, Kotoe, Gillard, Marc, Paner, Gladell, Imoto, Seiya, Yamaguchi, Rui, Wheeler, David, Lack, Justin, Cam, Maggie, Pontier, Andrea, Minh Nguyen, Yen Thi, Maejima, Kazuhiro, Sasaki-Oku, Aya, Nakano, Kaoru, Tanaka, Hiroko, Griend, Donald Vander, Kubo, Michiaki, Ratain, Mark J., Miyano, Satoru, Nakagawa, Hidewaki

Get full text Get full text Get full text

A case report of multiple primary prostate tumors with differential drug sensitivity by Wilkinson, Scott, Harmon, Stephanie A., Terrigino, Nicholas T., Karzai, Fatima, Pinto, Peter A., Madan, Ravi A., VanderWeele, David J., Lake, Ross, Atway, Rayann, Bright, John R., Carrabba, Nicole V., Trostel, Shana Y., Lis, Rosina T., Chun, Guinevere, Gulley, James L., Merino, Maria J., Choyke, Peter L., Ye, Huihui, Dahut, William L., Turkbey, Baris, Sowalsky, Adam G.

Get full text Get full text Get full text

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations by Karzai, Fatima, VanderWeele, David, Madan, Ravi A., Owens, Helen, Cordes, Lisa M., Hankin, Amy, Couvillon, Anna, Nichols, Erin, Bilusic, Marijo, Beshiri, Michael L., Kelly, Kathleen, Krishnasamy, Venkatesh, Lee, Sunmin, Lee, Min-Jung, Yuno, Akira, Trepel, Jane B., Merino, Maria J., Dittamore, Ryan, Marté, Jennifer, Donahue, Renee N., Schlom, Jeffrey, Killian, Keith J., Meltzer, Paul S., Steinberg, Seth M., Gulley, James L., Lee, Jung-Min, Dahut, William L.

Get full text Get full text Get full text

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-Risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is predictive of therapeutic response by Karzai, Fatima, Walker, Stephanie M., Wilkinson, Scott, Madan, Ravi A., Shih, Joanna H., Merino, Maria J., Harmon, Stephanie A., VanderWeele, David J., Cordes, Lisa M., Carrabba, Nicole V., Bright, John R., Terrigino, Nicolas T., Chun, Guinevere, Bilusic, Marijo, Couvillon, Anna, Hankin, Amy, Williams, Monique N., Lis, Rosina T., Ye, Huihui, Choyke, Peter L., Gulley, James L., Sowalsky, Adam G., Turkbey, Baris, Pinto, Peter A., Dahut, William L.

Get full text Get full text Get full text

Accelerating precision medicine in metastatic prostate cancer by Mateo, Joaquin, McKay, Rana, Abida, Wassim, Aggarwal, Rahul, Alumkal, Joshi, Alva, Ajjai, Feng, Felix, Gao, Xin, Graff, Julie, Hussain, Maha, Karzai, Fatima, Montgomery, Bruce, Oh, William, Patel, Vaibhav, Rathkopf, Dana, Rettig, Matthew, Schultz, Nikolaus, Smith, Matthew, Solit, David, Sternberg, Cora, Van Allen, Eliezer, VanderWeele, David, Vinson, Jake, Soule, Howard R., Chinnaiyan, Arul, Small, Eric, Simons, Jonathan W., Dahut, William, Miyahira, Andrea K., Beltran, Himisha

Get full text Get full text Get full text

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy by Wilkinson, Scott, Ye, Huihui, Karzai, Fatima, Harmon, Stephanie A., Terrigino, Nicholas T., VanderWeele, David J., Bright, John R., Atway, Rayann, Trostel, Shana Y., Carrabba, Nicole V., Whitlock, Nichelle C., Walker, Stephanie M., Lis, Rosina T., Sater, Houssein Abdul, Capaldo, Brian J., Madan, Ravi A., Gulley, James L., Chun, Guinevere, Merino, Maria J., Pinto, Peter A., Salles, Daniela C., Kaur, Harsimar B., Lotan, Tamara L., Venzon, David J., Choyke, Peter L., Turkbey, Baris, Dahut, William L., Sowalsky, Adam G.

Get full text Get full text Get full text